Providing the right vaccine(s) for young and old

The delicate balancing act between manufacturing enough of the yearly influenza vaccine that is widely administered in the fall and limiting the production of the forthcoming vaccine to control the H1N1 flu virus pandemic to children and people under 30 years old, raises competing constitunency concerns for Al Ozonoff, assistant professor of biostatistics who has studied the issues facing state and federal health officials.

Contact Al Ozonoff, 617-638-5866, aozonoff@bu.edu

Post a Comment

Your email address is never shared. Required fields are marked *